[{"id":"287a9ac5-c791-438b-9a3b-c10c40baeed2","acronym":"LAM-CAK","url":"https://clinicaltrials.gov/study/NCT05323370","created_at":"2022-04-12T14:53:02.668Z","updated_at":"2024-07-02T16:35:52.027Z","phase":"","brief_title":"Lymphangioleiomyomatosis, a Study on Cathepsin K","source_id_and_acronym":"NCT05323370 - LAM-CAK","lead_sponsor":"University Hospital, Tours","biomarkers":" VEGFD • CTSK","pipe":"","alterations":" ","tags":["VEGFD • CTSK"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 05/31/2022","start_date":" 05/31/2022","primary_txt":" Primary completion: 10/30/2022","primary_completion_date":" 10/30/2022","study_txt":" Completion: 10/30/2022","study_completion_date":" 10/30/2022","last_update_posted":"2023-03-29"}]